|
QURE
|
uniQure N.V.
|
0.54%
|
US
|
NASDAQ
|
|
INBX
|
Inhibrx, Inc.
|
0.54%
|
US
|
NASDAQ
|
|
IMVT
|
Immunovant, Inc.
|
0.54%
|
US
|
NASDAQ
|
|
CHRS
|
Coherus BioSciences, Inc.
|
0.54%
|
US
|
NASDAQ
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
0.54%
|
US
|
NASDAQ
|
|
VCEL
|
Vericel Corporation
|
0.50%
|
US
|
NASDAQ
|
|
AGEN
|
Agenus Inc.
|
0.50%
|
US
|
NASDAQ
|
|
ENTA
|
Enanta Pharmaceuticals, Inc.
|
0.49%
|
US
|
NASDAQ
|
|
KURA
|
Kura Oncology, Inc.
|
0.48%
|
US
|
NASDAQ
|
|
RXRX
|
Recursion Pharmaceuticals, Inc.
|
0.46%
|
US
|
NASDAQ
|
|
ICPT
|
Intercept Pharmaceuticals, Inc.
|
0.46%
|
US
|
NASDAQ
|
|
PTGX
|
Protagonist Therapeutics, Inc.
|
0.41%
|
US
|
NASDAQ
|
|
RAPT
|
RAPT Therapeutics, Inc.
|
0.40%
|
US
|
NASDAQ
|
|
MYGN
|
Myriad Genetics, Inc.
|
0.40%
|
US
|
NASDAQ
|
|
RGNX
|
REGENXBIO Inc.
|
0.39%
|
US
|
NASDAQ
|
|
VRDN
|
Viridian Therapeutics, Inc.
|
0.38%
|
US
|
NASDAQ
|
|
OCGN
|
Ocugen, Inc.
|
0.38%
|
US
|
NASDAQ
|
|
GERN
|
Geron Corporation
|
0.38%
|
US
|
NASDAQ
|
|
XNCR
|
Xencor, Inc.
|
0.37%
|
US
|
NASDAQ
|
|
MORF
|
Morphic Holding, Inc.
|
0.36%
|
US
|
NASDAQ
|